These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
65 related articles for article (PubMed ID: 15650243)
1. Oncogenic kinase signaling in human neoplasms. Tsatsanis C; Spandidos DA Ann N Y Acad Sci; 2004 Dec; 1028():168-75. PubMed ID: 15650243 [TBL] [Abstract][Full Text] [Related]
2. The insulin-like growth factor I receptor is required for Akt activation and suppression of anoikis in cells transformed by the ETV6-NTRK3 chimeric tyrosine kinase. Martin MJ; Melnyk N; Pollard M; Bowden M; Leong H; Podor TJ; Gleave M; Sorensen PH Mol Cell Biol; 2006 Mar; 26(5):1754-69. PubMed ID: 16478996 [TBL] [Abstract][Full Text] [Related]
3. The role of KLF6 and its splice variants in cancer therapy. DiFeo A; Martignetti JA; Narla G Drug Resist Updat; 2009; 12(1-2):1-7. PubMed ID: 19097929 [TBL] [Abstract][Full Text] [Related]
4. Oncogene addiction versus oncogene amnesia: perhaps more than just a bad habit? Felsher DW Cancer Res; 2008 May; 68(9):3081-6; discussion 3086. PubMed ID: 18451131 [TBL] [Abstract][Full Text] [Related]
5. Down-regulation of c-Myc following MEK/ERK inhibition halts the expression of malignant phenotype in rhabdomyosarcoma and in non muscle-derived human tumors. Marampon F; Ciccarelli C; Zani BM Mol Cancer; 2006 Aug; 5():31. PubMed ID: 16899113 [TBL] [Abstract][Full Text] [Related]
6. Oncogenic function of a novel WD-domain protein, STRAP, in human carcinogenesis. Halder SK; Anumanthan G; Maddula R; Mann J; Chytil A; Gonzalez AL; Washington MK; Moses HL; Beauchamp RD; Datta PK Cancer Res; 2006 Jun; 66(12):6156-66. PubMed ID: 16778189 [TBL] [Abstract][Full Text] [Related]
7. Targeting beta2-microglobulin mediated signaling as a novel therapeutic approach for human renal cell carcinoma. Nomura T; Huang WC; Seo S; Zhau HE; Mimata H; Chung LW J Urol; 2007 Jul; 178(1):292-300. PubMed ID: 17499801 [TBL] [Abstract][Full Text] [Related]
8. The c-Kit/D816V mutation eliminates the differences in signal transduction and biological responses between two isoforms of c-Kit. Pedersen M; Rönnstrand L; Sun J Cell Signal; 2009 Mar; 21(3):413-8. PubMed ID: 19049823 [TBL] [Abstract][Full Text] [Related]
9. Protein Kinase-zeta inhibits collagen I-dependent and anchorage-independent growth and enhances apoptosis of human Caco-2 cells. Mustafi R; Cerda S; Chumsangsri A; Fichera A; Bissonnette M Mol Cancer Res; 2006 Sep; 4(9):683-94. PubMed ID: 16940160 [TBL] [Abstract][Full Text] [Related]
10. Negative regulation of beta4 integrin transcription by homeodomain-interacting protein kinase 2 and p53 impairs tumor progression. Bon G; Di Carlo SE; Folgiero V; Avetrani P; Lazzari C; D'Orazi G; Brizzi MF; Sacchi A; Soddu S; Blandino G; Mottolese M; Falcioni R Cancer Res; 2009 Jul; 69(14):5978-86. PubMed ID: 19567674 [TBL] [Abstract][Full Text] [Related]
11. Rho GTPase expression in tumourigenesis: evidence for a significant link. Gómez del Pulgar T; Benitah SA; Valerón PF; Espina C; Lacal JC Bioessays; 2005 Jun; 27(6):602-13. PubMed ID: 15892119 [TBL] [Abstract][Full Text] [Related]
12. Down-regulation of Sprouty2 in non-small cell lung cancer contributes to tumor malignancy via extracellular signal-regulated kinase pathway-dependent and -independent mechanisms. Sutterlüty H; Mayer CE; Setinek U; Attems J; Ovtcharov S; Mikula M; Mikulits W; Micksche M; Berger W Mol Cancer Res; 2007 May; 5(5):509-20. PubMed ID: 17510316 [TBL] [Abstract][Full Text] [Related]
13. Differential effect of the focal adhesion kinase Y397F mutant on v-Src-stimulated cell invasion and tumor growth. Chang LC; Huang CH; Cheng CH; Chen BH; Chen HC J Biomed Sci; 2005; 12(4):571-85. PubMed ID: 16132110 [TBL] [Abstract][Full Text] [Related]
14. Mutant p53 attenuates the SMAD-dependent transforming growth factor beta1 (TGF-beta1) signaling pathway by repressing the expression of TGF-beta receptor type II. Kalo E; Buganim Y; Shapira KE; Besserglick H; Goldfinger N; Weisz L; Stambolsky P; Henis YI; Rotter V Mol Cell Biol; 2007 Dec; 27(23):8228-42. PubMed ID: 17875924 [TBL] [Abstract][Full Text] [Related]
15. A novel RET kinase-beta-catenin signaling pathway contributes to tumorigenesis in thyroid carcinoma. Gujral TS; van Veelen W; Richardson DS; Myers SM; Meens JA; Acton DS; Duñach M; Elliott BE; Höppener JW; Mulligan LM Cancer Res; 2008 Mar; 68(5):1338-46. PubMed ID: 18316596 [TBL] [Abstract][Full Text] [Related]
16. Secreted frizzled-related protein 4 inhibits proliferation and metastatic potential in prostate cancer. Horvath LG; Lelliott JE; Kench JG; Lee CS; Williams ED; Saunders DN; Grygiel JJ; Sutherland RL; Henshall SM Prostate; 2007 Jul; 67(10):1081-90. PubMed ID: 17476687 [TBL] [Abstract][Full Text] [Related]
17. Anoikis: a necessary death program for anchorage-dependent cells. Chiarugi P; Giannoni E Biochem Pharmacol; 2008 Dec; 76(11):1352-64. PubMed ID: 18708031 [TBL] [Abstract][Full Text] [Related]
18. ERKs in cancer: friends or foes? Deschênes-Simard X; Kottakis F; Meloche S; Ferbeyre G Cancer Res; 2014 Jan; 74(2):412-9. PubMed ID: 24408923 [TBL] [Abstract][Full Text] [Related]
19. Phosphatidylinositol phosphate 5-kinase Iγi2 in association with Src controls anchorage-independent growth of tumor cells. Thapa N; Choi S; Hedman A; Tan X; Anderson RA J Biol Chem; 2013 Nov; 288(48):34707-18. PubMed ID: 24151076 [TBL] [Abstract][Full Text] [Related]
20. The duality of human oncoproteins: drivers of cancer and congenital disorders. Castel P; Rauen KA; McCormick F Nat Rev Cancer; 2020 Jul; 20(7):383-397. PubMed ID: 32341551 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]